It was only yesterday when they said they were on the lookout for small acquisitions. Today's announcement concerning Wyeth again proves that management isn't always looking out for shareholder value.
But this may be the ring heard around the world concerning drug stocks. And a major buy for the lot.
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment